272 related articles for article (PubMed ID: 26760586)
1. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
Mantha S; Tallman MS; Soff GA
Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
[TBL] [Abstract][Full Text] [Related]
2. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
[TBL] [Abstract][Full Text] [Related]
6. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
7. The coagulopathy of acute promyelocytic leukaemia revisited.
Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
[TBL] [Abstract][Full Text] [Related]
8. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
[TBL] [Abstract][Full Text] [Related]
10. Optimal treatment strategies for high-risk acute promyelocytic leukemia.
Norsworthy KJ; Altman JK
Curr Opin Hematol; 2016 Mar; 23(2):127-36. PubMed ID: 26825698
[TBL] [Abstract][Full Text] [Related]
11. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
Kwaan HC; Cull EH
Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013
[TBL] [Abstract][Full Text] [Related]
12. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
Rodeghiero F; Castaman G
Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
Ikezoe T
Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy of acute promyelocytic leukemia.
Falanga A; Barbui T
Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
[TBL] [Abstract][Full Text] [Related]
16. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
18. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and management of coagulopathy in acute promyelocytic leukemia.
David S; Mathews V
Thromb Res; 2018 Apr; 164 Suppl 1():S82-S88. PubMed ID: 29703489
[TBL] [Abstract][Full Text] [Related]
20. Treatment of paediatric APL: how does the therapeutic approach differ from adults?
Kutny MA; Gregory J; Feusner JH
Best Pract Res Clin Haematol; 2014 Mar; 27(1):69-78. PubMed ID: 24907019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
